Target Price | $34.40 |
Price | $26.78 |
Potential |
28.45%
register free of charge
|
Number of Estimates | 15 |
15 Analysts have issued a price target Helmerich & Payne 2026 .
The average Helmerich & Payne target price is $34.40.
This is
28.45%
register free of charge
$43.00
60.57%
register free of charge
$24.00
10.38%
register free of charge
|
|
A rating was issued by 18 analysts: 5 Analysts recommend Helmerich & Payne to buy, 10 to hold and 3 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Helmerich & Payne stock has an average upside potential 2026 of
28.45%
register free of charge
|
Sep '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion $ | 2.76 | 3.75 |
4.03% | 35.86% | |
EBITDA Margin | 30.53% | 25.85% |
4.95% | 15.33% | |
Net Margin | 12.34% | 7.50% |
14.08% | 39.23% |
13 Analysts have issued a sales forecast Helmerich & Payne 2025 . The average Helmerich & Payne sales estimate is
This results in the following potential growth metrics:
14 Analysts have issued an Helmerich & Payne EBITDA forecast 2025. The average Helmerich & Payne EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
7 Helmerich & Payne Analysts have issued a net profit forecast 2025. The average Helmerich & Payne net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Sep '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | 3.43 | 2.83 |
17.55% | 17.49% | |
P/E | 9.46 | |
EV/Sales | 1.03 |
7 Analysts have issued a Helmerich & Payne forecast for earnings per share. The average Helmerich & Payne EPS is
This results in the following potential growth metrics and future valuations:
Helmerich & Payne...
Analyst | Rating | Action | Date |
---|---|---|---|
Morgan Stanley |
Locked
➜
Locked
|
Locked | Mar 27 2025 |
Barclays |
Locked
➜
Locked
|
Locked | Feb 19 2025 |
RBC Capital |
Locked
➜
Locked
|
Locked | Feb 07 2025 |
Evercore ISI Group |
Locked
➜
Locked
|
Locked | Jan 15 2025 |
Citigroup |
Locked
➜
Locked
|
Locked | Jan 10 2025 |
Benchmark |
Locked
➜
Locked
|
Locked | Nov 21 2024 |
Barclays |
Locked
➜
Locked
|
Locked | Nov 20 2024 |
Analyst Rating | Date |
---|---|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Mar 27 2025 |
Locked
Barclays:
Locked
➜
Locked
|
Feb 19 2025 |
Locked
RBC Capital:
Locked
➜
Locked
|
Feb 07 2025 |
Locked
Evercore ISI Group:
Locked
➜
Locked
|
Jan 15 2025 |
Locked
Citigroup:
Locked
➜
Locked
|
Jan 10 2025 |
Locked
Benchmark:
Locked
➜
Locked
|
Nov 21 2024 |
Locked
Barclays:
Locked
➜
Locked
|
Nov 20 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.